AstraZeneca (US Rights for Toprol-XL) Overview
- Latest Deal Type
- Financing Rounds
AstraZeneca (US Rights for Toprol-XL) General Information
Portfolio of distribution rights for a beta-blocker medicine. The portfolio consists of U.S. distribution rights for the branded and authorized generic drug designed for the treatment of hypertension (high blood pressure), angina (chest pain) and heart failure.
Corporate Backed or Acquired
Buildings and Property
- 2 Kingdom Street
- London W2 6BD
- England, United Kingdom
Want detailed data on 3M+ companies?
What you see here scratches the surfaceRequest a free trial
Want to dig into this profile?
We’ll help you find what you needLearn more
AstraZeneca (US Rights for Toprol-XL) Valuation & Funding
AstraZeneca (US Rights for Toprol-XL) Former Investors
|Investor Name||Investor Type||Holding||Investor Since||Participating Rounds||Contact Info|